cell_line:       A549;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HT29;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       A549;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       A673;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        AGS;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       CL34;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     CORL23;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     COV644;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       DV90;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      EFO27;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HA1E;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HA1E;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:      HCC15;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     HCC515;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     HCC515;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:     HCT116;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     HEC108;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      HEPG2;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      HT115;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HT29;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HT29;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:     JHUEM2;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       LOVO;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:      MDST8;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:   NCIH1694;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:   NCIH1836;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:   NCIH2073;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    NCIH508;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    NCIH596;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      NOMO1;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        OV7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       PL21;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       RMGI;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      RMUGS;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SKLU1;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       SKM1;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     SKMEL1;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    SKMEL28;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       SNGM;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    SNU1040;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SNUC4;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SNUC5;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SW480;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SW620;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SW948;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      T3M10;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       THP1;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      TYKNU;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       U937;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:   WSUDLCL2;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A549;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HA1E;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     HCC515;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:      HEPG2;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      HEPG2;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       3 ?M
cell_line:      HEPG2;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:      HEPG2;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       3 ?M
cell_line:       HUH7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HUH7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       3 ?M
cell_line:       HUH7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       HUH7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       3 ?M
cell_line:       MCF7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        PHH;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PHH;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       3 ?M
cell_line:        PHH;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        PHH;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       3 ?M
cell_line:    FIBRNPC;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    FIBRNPC;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        NEU;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        NEU;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:    NEU.KCL;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:  6 h & 4 h;    concentration:      10 ?M
cell_line:    NEU.KCL;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration: 24 h & 4 h;    concentration:      10 ?M
cell_line:        NPC;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        NPC;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:      H1299;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        RKO;    perturbation:    atorvastatin;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       BT20;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       1 ?M
cell_line:       BT20;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     100 nM
cell_line:     HS578T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:     HS578T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     500 nM
cell_line:     MCF10A;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     MCF10A;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       1 ?M
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       1 ?M
cell_line:   MDAMB231;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:   MDAMB231;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     500 nM
cell_line:      SKBR3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       A549;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A549;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       A673;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        AGS;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       CL34;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     CORL23;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     COV644;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       DV90;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      EFO27;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HA1E;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HA1E;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:      HCC15;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     HCC515;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     HCC515;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:     HCT116;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     HEC108;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      HEPG2;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      HT115;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HT29;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HT29;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:     JHUEM2;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       LOVO;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:      MDST8;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:   NCIH1694;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:   NCIH1836;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:   NCIH2073;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    NCIH508;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    NCIH596;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      NOMO1;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        OV7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       PL21;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       RMGI;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      RMUGS;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SKLU1;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       SKM1;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     SKMEL1;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    SKMEL28;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       SNGM;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    SNU1040;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SNUC4;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SNUC5;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SW480;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SW620;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      SW948;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       THP1;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      TYKNU;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       U937;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:   WSUDLCL2;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A549;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A549;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        ASC;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       HA1E;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     HCC515;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:      HEPG2;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HT29;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        NEU;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        NPC;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        PHH;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        SKB;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       BT20;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       BT20;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       1 ?M
cell_line:       BT20;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     500 nM
cell_line:       BT20;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     100 nM
cell_line:       BT20;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       BT20;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     500 nM
cell_line:     HS578T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     HS578T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       1 ?M
cell_line:     HS578T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     500 nM
cell_line:     HS578T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     100 nM
cell_line:     HS578T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       1 ?M
cell_line:     HS578T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     100 nM
cell_line:     MCF10A;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     500 nM
cell_line:     MCF10A;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     100 nM
cell_line:     MCF10A;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:     MCF10A;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       1 ?M
cell_line:     MCF10A;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     500 nM
cell_line:     MCF10A;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     100 nM
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     500 nM
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     100 nM
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       1 ?M
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     500 nM
cell_line:       MCF7;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     100 nM
cell_line:   MDAMB231;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       1 ?M
cell_line:   MDAMB231;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     100 nM
cell_line:   MDAMB231;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:   MDAMB231;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       1 ?M
cell_line:   MDAMB231;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     500 nM
cell_line:   MDAMB231;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     100 nM
cell_line:      SKBR3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       1 ?M
cell_line:      SKBR3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     500 nM
cell_line:      SKBR3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     100 nM
cell_line:      SKBR3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:      SKBR3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       1 ?M
cell_line:      SKBR3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     500 nM
cell_line:      SKBR3;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     100 nM
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       3 ?M
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     500 nM
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     100 nM
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       3 ?M
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     500 nM
cell_line:       A375;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     100 nM
cell_line:      H1299;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    HEK293T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:    HEK293T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:       3 ?M
cell_line:    HEK293T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     500 nM
cell_line:    HEK293T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:       24 h;    concentration:     100 nM
cell_line:    HEK293T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:    HEK293T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:       3 ?M
cell_line:    HEK293T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     500 nM
cell_line:    HEK293T;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:     100 nM
cell_line:        RKO;    perturbation:     vemurafenib;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HA1E;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HA1E;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:     HCC515;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:     HCC515;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:      HEPG2;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HT29;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A549;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A549;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       HA1E;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HT29;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       VCAP;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       A375;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A549;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       A549;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        ASC;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:      HEPG2;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       HT29;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        NPC;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        PHH;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        SKB;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:       MCF7;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:        6 h;    concentration:      10 ?M
cell_line:        PC3;    perturbation:     venlafaxine;    perturbation type:     trt_cp;    duration:       24 h;    concentration:      10 ?M
